GYRE THERAPEUTICS
GYRE THERAPEUTICS
Share · US4037831033 · GYRE · A3EE5F (XNCM)
Overview
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
9
4
0
0
No Price
15.12.2025 23:35
Current Prices from GYRE THERAPEUTICS
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
CBIO
USD
15.12.2025 23:35
13,41 USD
5,73 USD
+74,61 %
XDUS: Düsseldorf
Düsseldorf
GTIRSN33.DUSB
EUR
15.12.2025 11:31
6,50 EUR
-0,20 EUR
-2,99 %
XFRA: Frankfurt
Frankfurt
L9S.F
EUR
15.12.2025 07:23
6,55 EUR
-0,15 EUR
-2,24 %
XDQU: Quotrix
Quotrix
GTIRSN33.DUSD
EUR
15.12.2025 06:27
6,60 EUR
-0,10 EUR
-1,49 %
ESG Risk Rating
B Good
Share Float & Liquidity
Free Float 36,99 %
Shares Float 5,14 M
Shares Outstanding 13,89 M
Company Profile for GYRE THERAPEUTICS Share
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.
Get up to date insights from finAgent about GYRE THERAPEUTICS

Company Data

Name GYRE THERAPEUTICS
Company Crescent Biopharma, Inc.
Symbol GYRE
Website https://www.gyretx.com
Primary Exchange XNCM Frankfurt
WKN A3EE5F
ISIN US4037831033
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Joshua T. Brumm
Market Capitalization 685 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 300 5th Avenue, 02451 Waltham
IPO Date 2014-01-10
Dividends from 'GYRE THERAPEUTICS'
Ex-Date Dividend per Share
13.01.2023 0,02 USD
21.09.2022 0,36 USD
20.08.2015 0,14 USD

Stock Splits

Date Split
16.06.2025 1:100

ID Changes

Date From To
31.10.2023 CBIO GYRE
07.11.2015 TRGT CBIO
16.06.2025 GLYC CBIO

Ticker Symbols

Name Symbol
Düsseldorf GTIRSN33.DUSB
Frankfurt L9S.F
NASDAQ CBIO
NASDAQ GYRE
Quotrix GTIRSN33.DUSD
More Shares
Investors who hold GYRE THERAPEUTICS also have the following shares in their portfolio:
B.T.P. 17-48
B.T.P. 17-48 Bond
BSK 1818     PF.S.556
BSK 1818 PF.S.556 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025